NEW YORK, July 12 - Cellomics, the Pittsburgh, PA-based maker of integrated informatics and cell-screening technologies, has acquired Momentum Healthcare, a developer of drug discovery software, the company said Thursday.

Terms of the deal, which was formalized today but has been under negotiation for some time, were not disclosed and a company official declined to comment immediately.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.